Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Iqvia Holdings Inc. filings on SEC EDGAR ↗
Iqvia Holdings Insider Eric Sherbet Sells $1.24M of Stock
Eric Sherbet sold 4,446 shares of Iqvia Holdings Inc. at $278.83 a share, worth $1.24M in total on Nov 9, 2026. Shares held after the trade: 24,989 (-15.1%).
IQVIA reported third-quarter 2026 revenues of $4.43 billion, an 8% increase year-over-year, with net income attributable to the company rising to $350 million. For the first nine months of 2026, the company generated $2.0 billion in net cash from operating activities and utilized $950 million for common stock repurchases.
IQVIA reported third-quarter 2026 revenue of $4.43 billion, up 8.0% year-over-year, driven by strong growth in R&D Solutions and Commercial Solutions. The company achieved record clinical bookings of $3.2 billion and raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and Adjusted Diluted EPS.
“IQVIA delivered another record quarter, with revenue, Adjusted EBITDA and Adjusted Diluted EPS all exceeding the high end of our expectations. Multiple demand indicators continue to validate the strengthening market environment. EBP funding, RFP flow, clinical trial starts, FDA approvals, outsourcing trends, and pipeline growth across clinical and commercial are all favorable.”